This Study Evaluates the Diagnostic Performance and Safety of 68Ga-NYM032 PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer.

NCT07649122 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

232

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DIAGNOSTIC_TEST: 68-Ga-NYM032

Sponsor

Norroy Bioscience Co., LTD